QuanDx’ is a molecular diagnostics pioneer developing and commercialising innovative molecular tests, based on proprietary Yin Yang Probe technology for use in clinical and research laboratories worldwide. Graeme is leading and implementing the European, Middle East and Asian Sales and Marketing strategy to achieve the business growth in this specialised life science sector. He oversees the development of sales and marketing functions across international markets through extensive distribution partners as well as direct contact with clinical collaborators and end-users. QuanDx has molecular diagnostic products specialising in the personalised medicine approach for Leukemia, Lung Cancer and Infectious Diseases - HPV Genotyping, MRSA & TB Drug-Resistant Mutations.

Life Sciences Scotland represents the entire life sciences community in Scotland, from industry and academia to healthcare and government. The Life Sciences Scotland website is managed by the Editorial Committee, which is comprised of members of the Scottish life sciences community.

Responsible for the set up and ongoing day-to-day management of the European subsidiary in France. Management of the global sales and marketing function for both US and European companies. P & L responsibilities for the European subsidiary with close liason with the French accountants. Management of administrative personnel at subsidiary. Development of marketing strategies for new product opportunities and new product development. Coordinate international conferences and exhibitions. Liaise with US parent for development of marketing and promotional materials. Supervise the day-to-day activities of the US clinical application specialist. Management of global distributor network including development of business strategies for developing growth in the range of clinical diagnostic assays. Involvement in the establishment of educational workshops and seminars including presenting at international conferences.

Responsible for the establishment of a global commercial function for the company. Management of the commercial process from logistical administrative functions, pre-marketing activities, product packaging, preparation of the marketing materials, corporate web site, launch and establishment of direct sales activities and a distributor network. Recruitment of a Product Manager in 2003. Completed agreement with a US based manufacturer for the European distribution rights of a range of complimentary molecular pathology products in July 2003. Instrumental in establishing and management of clinical trial sites for the performance evaluation of a new clinical diagnostic tool launched as a CE marked IVD in October 2004. Active business development activities with key clinical centres in Europe and the USA for the development of new molecular tools to augment the existing product range offered by Ipsogen in both oncohaematology and solid tumours. Responsible for the pre-marketing activities of an innovative decentralised microarray for the management of breast cancer patients. This included identifying clinical needs with opinion leaders in pathology / oncology and input into the product design and validation of the final product. In 2005 instrumental in Ipsogen being accepted as a commercial partner of the European LeukemiaNet group.

Joined as International Sales & Marketing Manager with responsibility for the development, growth and expansion of the molecular genetics business worldwide. Establishment of a worldwide network of commercial partners and distributors in 30 key markets for commercialisation of molecular genetic products. Developed a strategic plan for the achievement of profitability for the commercial division by the year 2001. Recruitment of a commercial team comprising an International Sales Manager, Product Specialist, Customer Sales Administrator, Marketing Assistant and Technical Services Manager. Creation of a complete range of corporate and product literature and the development of a new corporate website. Responsibility for the R & D group (4 development scientists) on new product development. Appointed to the board as executive director on the 1st January 1999. Full profit & loss responsibility for the commercial group (sales, marketing & development). Achievement of corporate objectives in line with profit & loss forecast for financial year 2000 with growth of 51% over 1999 sales. Responsible for an increase in sales over the six-year period from £95,000 in 1995 to £1.1M in 2000. Completed strategic alliance between Cytocell and Quantum Appligene for DNA probe partnership in April 1999. Active in commercial discussions with suitable partners for licensing, development or marketing agreements for a range of gene detection molecular diagnostic assays.

Responsible for the pharmaceutical business development in international markets. Involvement in the clinical areas of oncology, haemophilia, neurology, ophthalmology and intensive care medicine. Management responsibility and accountability for the activity of partners and distributors throughout Europe, the Middle East and India. Experienced in the selection and appointment of partners and distributors with negotiation and completion of contractual agreements. Maintaining contact and close links with key international clinicians, organization of exhibitions, meetings and seminars and direct marketing input with co-ordination through distributors were key functions.

Involvement with the development and growth of a new company. Exposure to both external field work and internal company operations. Wide product experience with both the diagnostics and pharmaceutical areas of sales. Product management of the haematology range of diagnostic products. Achieved a significant contribution to the company in sales growth and in the successful launch of an innovative coagulation test kit. Experience gained in the UK hospital sales of pharmaceuticals to key consultants in the areas of oncology and haematology.

Experience in sales of diagnostic products to all departments of hospital laboratories. A formal training programme was undertaken during this time, which included Professional Selling Skills, Account Development Strategies and Professional Sales Negotiations courses. Contributed considerably to sales growth particularly in the instrumentation and haematology product ranges.